Scopus BioPharma Inc.
SCPS
$0.0003
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -6.81% | -41.54% | 8.84% | 42.81% | 28.78% |
| Total Depreciation and Amortization | 50.00% | 0.00% | -33.33% | -50.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.38% | -463.94% | -132.18% | -12.00% | 0.00% |
| Change in Net Operating Assets | -0.02% | 37.87% | 38.69% | 176.44% | -40.71% |
| Cash from Operations | -32.81% | -80.11% | 50.46% | 70.38% | 27.70% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.11% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -107.12% | 362.96% | -- | -- | -- |
| Cash from Financing | -102.21% | 734.81% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -16.18% | 374.60% | -205.00% | -89.51% | 424.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.40% | 785.77% | 77.98% | 70.00% | 28.98% |